Presymptomatic Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis.

ABSTRACT: Early stages of Huntington's disease (HD) before the onset of motor and cognitive symptoms are characterized by imbalanced excitatory and inhibitory output from the cortex to striatal and subcortical structures. The window before the onset of symptoms presents an opportunity to adjust the firing rate within microcircuits with the goal of restoring the impaired E/I balance, thereby preventing or slowing down disease progression. Here, we investigated the effect of presymptomatic cell-type specific manipulation of activity of pyramidal neurons and parvalbumin interneurons in the M1 motor cortex on disease progression in the R6/2 HD mouse model. Our results show that dampening excitation of Emx1 pyramidal neurons or increasing activity of parvalbumin interneurons once daily for 3 weeks during

SUBMITTER: Ikefuama EC 

PROVIDER: S-EPMC11291159 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature